Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris

Summary

The purpose of this study is to demonstrate the safety, tolerability and efficacy of B244 administered over 12 weeks to participants with mild to moderate acne vulgaris relative to placebo.

Timeline

Start

2016-08

Primary completion

2017-07-19

Completion

2017-07-19

Drugs

Indications